|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Johnson DH, Schiller JH and Bunn PA Jr:
Recent clinical advances in lung cancer management. J Clin Oncol.
32:973–982. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kang Y, Jia YL, Wang Q, Zhao Q, Song M, Ni
R and Wang J: Long noncoding RNA KCNQ1OT1 promotes the progression
of non-small cell lung cancer via regulating miR-204-5p/ATG3 axis.
Onco Targets Ther. 12:10787–10797. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chheang S and Brown K: Lung cancer
staging: Clinical and radiologic perspectives. Semin Intervent
Radiol. 30:99–113. 2013. View Article : Google Scholar :
|
|
5
|
Tang QL, Li MX, Chen L, Bi F and Xia HW:
miR-200b/c targets the expression of RhoE and inhibits the
proliferation and invasion of non-small cell lung cancer cells. Int
J Oncol. 53:1732–1742. 2018.PubMed/NCBI
|
|
6
|
Li Q, Yang Z, Chen M and Liu Y:
Downregulation of microRNA-196a enhances the sensitivity of
non-small cell lung cancer cells to cisplatin treatment. Int J Mol
Med. 37:1067–1074. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Moravcikova E, Krepela E, Donnenberg VS,
Donnenberg AD, Benkova K, Rabachini T, Fernandez-Marrero Y,
Bachmann D and Kaufmann T: BOK displays cell death-independent
tumor suppressor activity in non-small-cell lung carcinoma. Int J
Cancer. 141:2050–2061. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nagano T and Fraser P: No-nonsense
functions for long noncoding RNAs. Cell. 145:178–181. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cui M, Chen M, Shen Z, Wang R, Fang X and
Song B: LncRNA-UCA1 modulates progression of colon cancer through
regulating the miR-28-5p/HOXB3 axis. J Cell Biochem. Jan
16–2019.Epub ahead of print. View Article : Google Scholar
|
|
11
|
Pan Z, Mao W, Bao Y, Zhang M, Su X and Xu
X: The long noncoding RNA CASC9 regulates migration and invasion in
esophageal cancer. Cancer Med. 5:2442–2447. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang CG, Liao Z, Xiao H, Liu H, Hu YH,
Liao QD and Zhong D: LncRNA KCNQ1OT1 promoted BMP2 expression to
regulate osteogenic differentiation by sponging miRNA-214. Exp Mol
Pathol. 107:77–84. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lv J, Qiu M, Xia W, Liu C, Xu Y, Wang J,
Leng X, Huang S, Zhu R, Zhao M, et al: High expression of long
non-coding RNA SBF2-AS1 promotes proliferation in non-small cell
lung cancer. J Exp Clin Cancer Res. 35:752016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lou B, Wei D, Zhou X and Chen H: Long
non-coding RNA KDM5B anti-sense RNA1 enhances tumor progression in
non-small cell lung cancer. J Clin Lab Anal. 34:e228972020.
View Article : Google Scholar
|
|
15
|
Zhang Z, Peng Z, Cao J, Wang J, Hao Y,
Song K, Wang Y, Hu W and Zhang X: Long noncoding RNA PXN-AS1-L
promotes non-small cell lung cancer progression via regulating PXN.
Cancer Cell Int. 19:202019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li N and Zhan X and Zhan X: The lncRNA
SNHG3 regulates energy metabolism of ovarian cancer by an analysis
of mitochondrial proteomes. Gynecol Oncol. 150:343–354. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xuan Y and Wang Y: Long non-coding RNA
SNHG3 promotes progression of gastric cancer by regulating
neighboring MED18 gene methylation. Cell Death Dis. 10:6942019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu L, Ni J and He X: Upregulation of the
long noncoding RNA SNHG3 promotes lung adenocarcinoma
proliferation. Dis Markers. 2018:57367162018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
20
|
Takaoka K, Kishimoto H, Segawa E,
Hashitani S, Zushi Y, Noguchi K, Sakurai K and Urade M: Elevated
cell migration, invasion and tumorigenicity in human KB carcinoma
cells transfected with COX-2 cDNA. Int J Oncol. 29:1095–1101.
2006.PubMed/NCBI
|
|
21
|
Yang Z, Li K, Liang Q, Zheng G, Zhang S,
Lao X, Liang Y and Liao G: Elevated hydrostatic pressure promotes
ameloblastoma cell invasion through upregulation of MMP-2 and MMP-9
expression via Wnt/β-catenin signalling. J Oral Pathol Med.
47:836–846. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chu J, Jia J, Yang L, Qu Y, Yin H, Wan J
and He F: LncRNA MIR31HG functions as a ceRNA to regulate c-Met
function by sponging miR-34a in esophageal squamous cell carcinoma.
Biomed Pharmacother. 128:1103132020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Feng L, Yang B and Tang XD: Long noncoding
RNA LINC00460 promotes carcinogenesis via sponging miR-613 in
papillary thyroid carcinoma. J Cell Physiol. 234:11431–11439. 2019.
View Article : Google Scholar
|
|
24
|
Zhang F, Chen D, Yang W, Duan SZ and Chen
Y: Combined effects of XAF1 and TRAIL on the apoptosis of lung
adenocarcinoma cells. Exp Ther Med. 17:4663–4669. 2019.PubMed/NCBI
|
|
25
|
Zhang X and Xiao C: Ultrasonic diagnosis
combined with targeted ultrasound contrast agent improves
diagnostic sensitivity of ultrasonic for non-small cell lung cancer
patients. Exp Ther Med. 16:908–916. 2018.PubMed/NCBI
|
|
26
|
Chen H, Pei H, Hu W, Ma J, Zhang J, Mao W,
Nie J, Xu C, Li B, Hei TK, et al: Long non-coding RNA CRYBG3
regulates glycolysis of lung cancer cells by interacting with
lactate dehydrogenase A. J Cancer. 9:2580–2588. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shangguan WJ, Liu HT, Que ZJ, Qian FF, Liu
LS and Tian JH: TOB1-AS1 suppresses non-small cell lung cancer cell
migration and invasion through a ceRNA network. Exp Ther Med.
18:4249–4258. 2019.PubMed/NCBI
|
|
28
|
Aghdam SG, Ebrazeh M, Hemmatzadeh M,
Seyfizadeh N, Shabgah AG, Azizi G, Ebrahimi N, Babaie F and
Mohammadi H: The role of microRNAs in prostate cancer migration,
invasion, and metastasis. J Cell Physiol. 234:9927–9942. 2019.
View Article : Google Scholar
|
|
29
|
Wu JS, Jiang J, Chen BJ, Wang K, Tang YL
and Liang XH: Plasticity of cancer cell invasion: Patterns and
mechanisms. Transl Oncol. 14:1008992021. View Article : Google Scholar
|
|
30
|
Bogenrieder T and Herlyn M: Axis of evil:
Molecular mechanisms of cancer metastasis. Oncogene. 22:6524–6536.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guo FJ, Tian JY, Jin YM, Wang L, Yang RQ
and Cui MH: Effects of cyclooxygenase-2 gene silencing on the
biological behavior of SKOV3 ovarian cancer cells. Mol Med Rep.
11:59–66. 2015. View Article : Google Scholar
|
|
32
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: Regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Leung E, McArthur D, Morris A and Williams
N: Cyclooxygenase-2 inhibition prevents migration of colorectal
cancer cells to extracellular matrix by down-regulation of matrix
metalloproteinase-2 expression. Dis Colon Rectum. 51:342–347. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wagenaar-Miller RA, Hanley G,
Shattuck-Brandt R, DuBois RN, Bell RL, Matrisian LM and Morgan DW:
Cooperative effects of matrix metalloproteinase and
cyclooxygenase-2 inhibition on intestinal adenoma reduction. Br J
Cancer. 88:1445–1452. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pan J, Yang Q, Shao J, Zhang L, Ma J, Wang
Y, Jiang BH, Leng J and Bai X: Cyclooxygenase-2 induced β1-integrin
expression in NSCLC and promoted cell invasion via the
EP1/MAPK/E2F-1/FoxC2 signal pathway. Sci Rep. 6:338232016.
View Article : Google Scholar
|
|
36
|
Xia M, Duan ML, Tong JH and Xu JG: MiR-26b
suppresses tumor cell proliferation, migration and invasion by
directly targeting COX-2 in lung cancer. Eur Rev Med Pharmacol Sci.
19:4728–4737. 2015.
|
|
37
|
Li W, Li N, Shi K and Chen Q: Systematic
review and meta-analysis of the utility of long non-coding RNA GAS5
as a diagnostic and prognostic cancer biomarker. Oncotarget.
8:66414–66425. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Guo W, Ren D, Chen X, Tu X, Huang S, Wang
M, Song L, Zou X and Peng X: HEF1 promotes epithelial mesenchymal
transition and bone invasion in prostate cancer under the
regulation of microRNA-145. J Cell Biochem. 114:1606–1615. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Longqiu Y, Pengcheng L, Xuejie F and Peng
Z: A miRNAs panel promotes the proliferation and invasion of
colorectal cancer cells by targeting GABBR1. Cancer Med.
5:2022–2031. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hu Y, Wang H, Chen E, Xu Z, Chen B and Lu
G: Candidate microRNAs as biomarkers of thyroid carcinoma: A
systematic review, meta-analysis, and experimental validation.
Cancer Med. 5:2602–2614. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kim HJ, Yang JM, Jin Y, Jheon S, Kim K,
Lee CT, Chung JH and Paik JH: MicroRNA expression profiles and
clinicopathological implications in lung adenocarcinoma according
to EGFR, KRAS, and ALK status. Oncotarget. 8:8484–8498. 2017.
View Article : Google Scholar :
|
|
42
|
Yuan T, Huang X, Woodcock M, Du M, Dittmar
R, Wang Y, Tsai S, Kohli M, Boardman L, Patel T and Wang L: Plasma
extracellular RNA profiles in healthy and cancer patients. Sci Rep.
6:194132016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xu H, Zhang Y, Qi L, Ding L, Jiang H and
Yu H: NFIX circular RNA promotes glioma progression by regulating
miR-34a-3p via notch signaling pathway. Front Mol Neurosci.
11:2252018. View Article : Google Scholar
|
|
44
|
Kleemann M, Schneider H, Unger K, Sander
P, Schneider EM, Fischer-Posovszky P, Handrick R and Otte K:
MiR-744-5p inducing cell death by directly targeting HNRNPC and
NFIX in ovarian cancer cells. Sci Rep. 8:90202018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ge J, Dong H, Yang Y, Liu B, Zheng M,
Cheng Q, Peng L and Li J: NFIX downregulation independently
predicts poor prognosis in lung adenocarcinoma, but not in squamous
cell carcinoma. Future Oncol. 14:3135–3144. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Rahman NIA, Abdul Murad NA, Mollah MM,
Jamal R and Harun R: NFIX as a master regulator for lung cancer
progression. Front Pharmacol. 8:5402017. View Article : Google Scholar :
|
